ACCA Strategic Professional · Strategic Business Reporting (International) · Share-based payment
Brava Co has a cash-settled scheme with a two-year vesting period. The liability at 31 December 20X1 was $300,000. During 20X2 (the vesting date), the SARs were fully vested, no employees left, and the total fair value of the SARs at 31 December 20X2 is $720,000. No cash has yet been paid. What is the expense recognised in profit or loss for 20X2?
The 20X2 expense is $420,000. At the end of the vesting period the liability must equal the full fair value of $720,000, and since $300,000 was already recognised in 20X1, the difference of $420,000 is charged to profit or loss.
- A$360,000
- B$420,000Correct
- C$720,000
- D$300,000
Explanation
At the end of the vesting period the liability must equal the full fair value of $720,000. The expense for 20X2 is the movement in the liability: $720,000 - $300,000 = $420,000. The $360,000 option is half of the total, ignoring the cumulative catch-up that reflects the change in fair value in year 1.
Did you get it right without looking?
One question tells you little. A timed set on Share-based payment shows your real accuracy, how long you take and where you lose marks.
More Share-based payment questions
- Orion Ltd agrees to give its chief executive a cash bonus at the end of year 3 equal to the value of 10,000 Orion shares at that date, provi…
- Echo Co grants share options to employees on 1 January 20X1 with a grant-date fair value of $5 per option. At 31 December 20X1 the fair valu…
- A finance director of Omega plc, whose bonus includes share options vesting only if reported profit exceeds a target, asks the financial con…
- Which transaction falls outside the scope of IFRS 2?
- Zeta plc grants an employee a share-based payment under which Zeta can choose at vesting either to issue 1,000 shares or to pay cash equal t…
- Which of the following transactions falls within the scope of IFRS 2?